Connection

Kent Armeson to Carcinoma, Squamous Cell

Back to Details
This is a "connection" page, showing publications Kent Armeson has written about Carcinoma, Squamous Cell.
Kent Armeson
Connection Strength
0.638
Carcinoma, Squamous Cell
  1. Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
    View in: PubMed
    Score: 0.141
  2. Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma. BMC Cancer. 2020 Mar 17; 20(1):229.
    View in: PubMed
    Score: 0.127
  3. Comparison of psychosocial factors over time among HPV+ oropharyngeal cancer and tobacco-related oral cavity cancer patients. Am J Otolaryngol. 2019 Jan - Feb; 40(1):40-45.
    View in: PubMed
    Score: 0.114
  4. Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review. Arch Dermatol Res. 2017 May; 309(4):243-251.
    View in: PubMed
    Score: 0.103
  5. Cervical esophageal cancer: a population-based study. Head Neck. 2015 Jun; 37(6):808-14.
    View in: PubMed
    Score: 0.085
  6. Cetuximab therapy for head and neck squamous cell carcinoma: a systematic review of the data. Otolaryngol Head Neck Surg. 2011 May; 144(5):676-84.
    View in: PubMed
    Score: 0.068
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.